Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-A prospective cohort study

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 553-560

  Haase Fielitz, Anja ^a,c   Bellomo, Rinaldo ^a   Devarajan, Prasad ^d   Story, David ^b   Matalanis, George ^b   Dragun, Duska ^c   Haase, Michael ^a,c  

^a Department of Intensive Care ^*  (Australia)

^b AUSTIN HEALTH   (Australia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Cardiac surgery; Plasma neutrophil gelatinase associated lipocalin; Renal replacement therapy; Serum creatinine; Serum cystatin C; Serum urea

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FUROSEMIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UREA;

ACUTE KIDNEY INJURY; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CREATININE; CYSTATIN C; FEMALE; HUMANS; INTENSIVE CARE; INTRAOPERATIVE COMPLICATIONS; KIDNEY; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; UREA;

EID: 67649761548     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318195846e     Document Type: Article

References (21)

1. Ostermann ME, Taube D, Morgan CJ, et al: Acute renal failure following cardiopulmo-nary bypass: A changing picture. Intensive Care Med 2000; 26:565-571
2. Leacche M, Rawn JD, Mihaljevic T, et al: Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol 2004; 93:353-356
3. Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818
4. Haase M, Haase-Fielitz A, Bagshaw SM, et al: Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgical patients. Crit Care Med 2007; 35:1324-1331
5. Stafford-Smith M, Podgoreanu M, Swami-nathan M, et al: Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005; 45:519-530
6. Herget-Rosenthal S, Marggraf G, Hüsing J, et al: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122
7. Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238
8. Wagener G, Jan M, Kim M, et al: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after adult cardiac surgery. Anesthesiology 2006; 105:485-491
9. Zhu J, Yin R, Wu H, et al: Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass. Clin Chim Acta 2006; 374:116-121
10. Abu-Omar Y, Mussa S, Naik MJ, et al: Evaluation of cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery. Eur J Cardiothorac Surg 2005; 27:893-898
11. Levey AS, Coresh J, Greene T, et al: Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creati-nine values. Clin Chem 2007; 53:766-772
12. Nashef SA, Roques F, Michel P, et al: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
13. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843
14. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
15. Schmitt-Ott KM, Mori K, Li JY, et al: Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18:407-413
16. Nickolas TL, O'Rourke MJ, Yang J, et al: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148:810-819
17. Sambasivan AS, Lepage N, Filler G: Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine. Clin Chem 2005; 51:2215-2216
18. Newman DJ: Cystatin C. Ann Clin Biochem 2002; 39:89-104
19. Boldt J, Brosch C, Ducke M, et al: Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 2007; 35: 2740-2746
20. Jönsson P, Stahl ML, Ohlsson K: Extracorporeal circulation causes release of neutrophil gelatinase-associated lipocalin. Mediators Inflamm 1999; 8:169-171
21. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17:1503-1520